Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

The Clinical Value of Prognostic Nutritional Index in CAR-T Therapy for Patients with Malignant Lymphoma

Na Zhang, Rui Liu, Fan Yang, Lixia Ma, Yuelu Guo, Zhonghua Fu, Haifeng Wu, Biping Deng, Xiaoyan Ke, Kai Hu

Blood (2024) 144 (Supplement 1): 1745.

https://doi.org/10.1182/blood-2024-202403

Published: 2024

Journal Articles

Treatment Outcomes for Patients with TP53 -Mutated Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis

Na Zhang, Jiegang Xu, Chengxin Luo, Dongfeng Zeng, Shuangnian Xu, Xi Li

Blood (2024) 144 (Supplement 1): 3041.

https://doi.org/10.1182/blood-2024-209480

Published: 2024

Journal Articles

Effects of BMI, Albumin and NRS 2002 Changes on Prognosis in Patients with Hematological Malignancies during CAR T Treatment

NA Zhang, Kai Hu

Blood (2022) 140 (Supplement 1): 3814–3815.

https://doi.org/10.1182/blood-2022-163154

Published: 2022

Journal Articles

NUDT21 Modulates Pign through APA Mechanism to Affect the Progression of MDS and AML

Jeffrey J. Pu, Fanggang Ren, Na Zhang, Shuo Li, Lan Zhang, Eric Miller, Guirong Wang, Hongwei Wang

Blood (2022) 140 (Supplement 1): 11481–11482.

https://doi.org/10.1182/blood-2022-166604

Published: 2022

Journal Articles

Clinical Nursing during CD4-Specific CAR T Cells Treatment for One Mycosis Fungoides Patient Improves Generalized Skin Lesion

NA Zhang, Kai Hu, Xiaoyan Ke

Blood (2021) 138 (Supplement 1): 4974.

https://doi.org/10.1182/blood-2021-151910

Published: 2021

Journal Articles

Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients (Pts) with Very High/High-Risk Myelodysplastic Syndrome (vHR/HR-MDS) and Acute Myeloid Leukemia (AML): Final Analysis from a Phase Ib Study

Blood (2021) 138 (Supplement 1): 244.

https://doi.org/10.1182/blood-2021-146039

Published: 2021

Journal Articles

Sabatolimab (MBG453) Dose Selection and Dose-Response Analysis in Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML): Population Pharmacokinetics (PK) Modeling and Evaluation of Clinical Efficacy/Safety By Dose

Blood (2020) 136 (Supplement 1): 40–42.

https://doi.org/10.1182/blood-2020-137307

Published: 2020

Journal Articles

Treatment for X-Linked Agammaglobulinemia with Allogeneic Umbilical Cord Blood Stem Cell Transplantation from HLA-Matched Sibling Confirmed Healthy through Prenatal Diagnosis

Dingming Wan, Ran Zhang, Meng Wang, Li Li, Weijie Cao, Suping Zhang, Kai Sun, MD, Xiaona Chen, Na Zhang

Blood (2018) 132 (Supplement 1): 5771.

https://doi.org/10.1182/blood-2018-99-116135

Published: 2018

Journal Articles

Identification of Novel Fusion Genes and Characterization of Transcriptome Features in T-Cell Acute Lymphoblastic Leukemia

Bing Chen, MD PhD, Jiang LU, PhD, Meng-Ling Zhong, Jian-Feng LI, Ben-Shang LI, MD, Li-Jun Peng, Yu-Ting Dai, Wei-Na Zhang, PhD, Su-Ning Chen, MD PhD, Jianda Hu, Prof MDPhD, De-pei Wu, MDPhD, Zhu Chen, Jing-Yan Tang, MD, Jin-yan Huang, PhD, Jian-Qing Mi, MD PhD, Sai-Juan Chen, MD PhD

Blood (2017) 130 (Supplement 1): 2724.

https://doi.org/10.1182/blood.V130.Suppl_1.2724.2724

Published: 2017

Journal Articles

Treatment with Low-Dose Daunorubicin Reduces the Number of Leukemia Stem Cells in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Tara L. Lin, MD, John M. Perry, PhD, Xi He, MD, Raymond P. Perez, MD, Gregory Reed, PhD, Margaret M. Brophy, Na Zhang, PhD, Scott Weir, PharmD, PhD, Joseph P. McGuirk, DO, Linheng Li, PhD

Blood (2017) 130 (Supplement 1): 1336.

https://doi.org/10.1182/blood.V130.Suppl_1.1336.1336

Published: 2017

Journal Articles

Functional Study of Novel Gene Fusions and Patterns of Epigenetic Regulator Mutations in Adult and Childhood B-Cell Acute Lymphoblastic Leukemia

Wei-Na Zhang, Ming Zhang, Jin-yan Huang, Zhu Chen, Sai-Juan Chen

Blood (2016) 128 (22): 4076.

https://doi.org/10.1182/blood.V128.22.4076.4076

Published: 2016

Journal Articles

Genome-Wide Abnormality Patterns of B-Lineage Acute Lymphoblastic Leukemia in Adults in Comparison with Pediatric Cases

Blood (2014) 124 (21): 3786.

https://doi.org/10.1182/blood.V124.21.3786.3786

Published: 2014

Journal Articles

Serum 2-Hydroxyglutarate Level Is a Prognostic Marker in Acute Myeloid Leukemia

Blood (2012) 120 (21): 1433.

https://doi.org/10.1182/blood.V120.21.1433.1433

Published: 2012

Journal Articles

DNMT3A Mutation Leads to Hematopoietic Dysregulation.

Jie Xu, Wei-na Zhang, Tao Zhen, Yang Li, Jing-yi Shi, Jian-qing Mi, Yue-ying Wang, Sai-juan Chen, Zhu Chen

Blood (2012) 120 (21): 2382.

https://doi.org/10.1182/blood.V120.21.2382.2382

Published: 2012

Journal Articles

Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia

Li-Juan Zhao, Yue-Ying Wang, Guo Li, Li-Yuan Ma, Shu-Min Xiong, Xiang-Qin Weng, Wei-Na Zhang, Bo Wu, Zhu Chen, Sai-Juan Chen

Blood (2012) 119 (12): 2873–2882.

https://doi.org/10.1182/blood-2011-08-370981

Published: 2012

Includes: Supplemental data

Journal Articles

The BH3-Only Protein Puma Plays An Essential Role in p53-Mediated Apoptosis of Chronic Lymphocytic Leukemia Cells

Wei Xu, MD, PhD, Hai-Jia Zhu, Li-Na Zhang, Lei Fan, Cheng Fang, Dan-Xia Zhu, Yin-Hua Wang, Jian-Yong Li, MD, PhD

Blood (2011) 118 (21): 4592.

https://doi.org/10.1182/blood.V118.21.4592.4592

Published: 2011

NARROW

The Clinical Value of Prognostic Nutritional Index in CAR-T Therapy for Patients with Malignant Lymphoma

Treatment Outcomes for Patients with TP53 -Mutated Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis

Effects of BMI, Albumin and NRS 2002 Changes on Prognosis in Patients with Hematological Malignancies during CAR T Treatment

NUDT21 Modulates Pign through APA Mechanism to Affect the Progression of MDS and AML

Clinical Nursing during CD4-Specific CAR T Cells Treatment for One Mycosis Fungoides Patient Improves Generalized Skin Lesion

Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients (Pts) with Very High/High-Risk Myelodysplastic Syndrome (vHR/HR-MDS) and Acute Myeloid Leukemia (AML): Final Analysis from a Phase Ib Study

Sabatolimab (MBG453) Dose Selection and Dose-Response Analysis in Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML): Population Pharmacokinetics (PK) Modeling and Evaluation of Clinical Efficacy/Safety By Dose

Treatment for X-Linked Agammaglobulinemia with Allogeneic Umbilical Cord Blood Stem Cell Transplantation from HLA-Matched Sibling Confirmed Healthy through Prenatal Diagnosis

Identification of Novel Fusion Genes and Characterization of Transcriptome Features in T-Cell Acute Lymphoblastic Leukemia

Treatment with Low-Dose Daunorubicin Reduces the Number of Leukemia Stem Cells in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Functional Study of Novel Gene Fusions and Patterns of Epigenetic Regulator Mutations in Adult and Childhood B-Cell Acute Lymphoblastic Leukemia

Genome-Wide Abnormality Patterns of B-Lineage Acute Lymphoblastic Leukemia in Adults in Comparison with Pediatric Cases

Serum 2-Hydroxyglutarate Level Is a Prognostic Marker in Acute Myeloid Leukemia

DNMT3A Mutation Leads to Hematopoietic Dysregulation.

Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia

The BH3-Only Protein Puma Plays An Essential Role in p53-Mediated Apoptosis of Chronic Lymphocytic Leukemia Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only